Frontiers in Medicine (Jan 2022)

Saliva Sampling for Prospective SARS-CoV-2 Screening of Healthcare Professionals

  • Adalbert Raimann,
  • Alex Farr,
  • Mercedes Huscsava,
  • Wilfried Krois,
  • Robert Strassl,
  • Julia Schellnegger,
  • Fabian Eibensteiner,
  • Bernadette Göschl,
  • Hannah Schned,
  • Philipp Steinbauer,
  • Mathias Hetzmannseder,
  • Fabian Stiegner,
  • Susanne Greber-Platzer,
  • Herbert Kiss,
  • Paul L. Plener,
  • Paul L. Plener,
  • Christoph Aufricht,
  • Angelika Berger,
  • Michael Wagner

DOI
https://doi.org/10.3389/fmed.2022.823577
Journal volume & issue
Vol. 9

Abstract

Read online

ObjectiveThe objective of this study was to analyze the feasibility and acceptance of a non-invasive, daily and proactive screening program for SARS-CoV-2 infection employing serial saliva testing, in combination with a digital questionnaire among healthcare providers (HCPs) in a multi-professional setting.DesignThis was a prospective cohort study involving HCPs from different units at a single tertiary care center, over a pilot phase of 4 weeks during the first wave of the COVID-19 pandemic from April 18th to June 6th, 2020.SettingPediatric tertiary patient care units, Comprehensive Center for Pediatrics, Medical University of Vienna.SubjectsHCPs from different units, including physicians, nurses, midwives, and administrative staff (with patient contact) were considered eligible for the study. Study participants were working in different settings in our center at varying levels of risk exposure.InterventionsSaliva collection from mouth gargle and electronic symptom and exposure monitoring (eSEM) was performed by participants at the onset of each regular clinical shift (day or night shift), using an anonymous ID for matching the results.MeasurementsRT-PCR of all saliva samples, eSEM, as well as feasibility and acceptance thereof.ResultsTwo hundred and seventy-five volunteers collected 1,865 saliva samples and responded 1,378 times in the eSEM during a 4-week period. 1,331 (96.7%) responses were that the testing was feasible and acceptable. The most common severe symptom during the 4-week period mentioned by HCPs was headache, reported 54 times (3.9%). Two SARS-CoV-2 positive samples—one of them being associated with symptoms—were identified. The acceptance rate among HCPs was 96.6%.ConclusionSerial saliva screening was a well-accepted and feasible method for monitoring SARS-CoV-2 infectious state in health care professionals. Combination of regular SARS-CoV-2 tests with sequential saliva collection and storage could potentially represent a highly efficient strategy to identify and trace virus positive staff for employee and patient safety.

Keywords